Sfoglia per AUTORE
CRIVELLI F
Collezione ASL Biella
Items : 9
Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening in Journal of Translational Medicine
2025
ASL Biella
Peraldo-Neia C; Ostano P; Savioli M; Mello-Grand M; Gregnanin I; Guana F; Crivelli F; Montagnani F; Dei-Cas M; Paroni R; Sinopoli A; Ferranti F; Testino N; Oderda M; Zitella A; Fiameni C; Gagliardi A; Naccarati A; Clivio L; Gontero P; Zaramella S; Chiorino G;
2025
ASL Biella
ASL VCO
Leone F; Fiamma V; Crivelli F; Paris MK; Forti LG; Brizzi MP; Sperti E; Laface R; Tober N; Salerno F; Traverso ES; Parlagreco E; Nepote A; Giuli A; Bonessio E; Nicolì E; Bertola B; Montagnani F;
Combined single-photon emission computed tomography-myocardial perfusion imaging with coronary calcium score for assessing coronary disease in Nuclear Medicine Communications
2025
ASL Biella
Calandri E; Verdoia M; Sirovich R; Giraudo MT; Pultrone M; Frantellizzi V; Viola O; Crivelli F; Gallina S; Serralunga M; Rognoni A; De Vincentis G;
Survey on symptoms in patients receiving chemotherapy in an Italian department of oncology: a comparison between period prevalences. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jan;29(1):255-261. doi: 10.1007/s00520-020-05486-x. Epub 2020 Apr 28.
2021
ASL Biella
Crivelli F; Perfetti E; Sartorello B; Cantele V; Ostano P; Ilardi F; Di Massimo DS; Clerico M;
Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database in Journal of Clinical Oncology
2020
ASL Biella
Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Cigliola A; Moreno I; Rubio J; Crivelli F; Shaw G; Petrioli R; Bengala C; Francini G; Foncillas JG; Sweeney C; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC;
Efficacy of bone resorption inhibitors (BRI) + abiraterone acetate + prednisone (AA) vs. AA alone as first-line therapy for men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) in an international multicenter hospital-based registry in Journal of Clinical Oncology
2019
ASL Biella
Francini E; Montagnani F; Vitale NP; Alimohamed NS; Candilejo IM; Rosellini P; Gonzalez-Velez M; Rubio J; Zhang L; Shaw G; Crivelli F; Petrioli R; Bengala C; Francini G; Foncillas JG; Bryce AH; Sweeney C; Harshman LC; Lee-Ying R; Heng DYC;
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer in British Journal of Cancer
2019
ASL Biella
Fornaro L; Vivaldi C; Parnofiello A; Ugolini C; Aprile G; De Maglio G; Pecora I; Iacono D; Crivelli F; Catanese S; Cardellino GG; Lencioni M; Vasile E; Salani F; Clerico M; Calvetti L; Falcone A; Fasola G; Fontanini G; Montagnani F;
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors in Cancer Treatment Reviews
2018
ASL Biella
Montagnani F; Crivelli F; Aprile G; Vivaldi C; Pecora I; De Vivo R; Clerico MA; Fornaro L;
Predicting HER2 status in esophagogastric cancer: Development and validation of an easy-to-use nomogram in Annals of Oncology
2018
ASL Biella
Fornaro L; Parnofiello A; Ugolini C; Cardarelli N; De Maglio G; Pecora I; Crivelli F; Catanese S; Cardellino G; Musettini G; Pella N; Pasquini G; Pizzolitto S; Salani F; Clerico M; Fontanini G; Fasola G; Maurizio D; Vivaldi C; Montagnani F;